2,2-dimethly-1,3-dioxolane derivatives (Beijing Institute of Pharmacology and Toxicology)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Name2,2-dimethly-1,3-dioxolane derivatives (Beijing Institute of Pharmacology and Toxicology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPicornain 3C protease inhibitors
TargetsPicornain 3C protease
Therapy Area/IndicationsRhinovirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Institute for Drug Control
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Institute for Drug Control
Active IndicationsN/A
Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A
Related LinksN/A